Inventor · Guilford, CT, US

William Scott

44Patents
16h-index
130Co-inventors
84Inventor score

Filing activity: May 15, 1997 → Jan 5, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US7838541B2 Aryl ureas with angiogenesis inhibiting activity Emerging Cross-Sectional Technologies 52 Expired
US7329670B1 Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas Chemistry; Metallurgy 49 Expired
US7235576B1 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Chemistry; Metallurgy 47 Expired
US8071616B2 Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors Chemistry; Metallurgy 44 Active
US7678811B2 Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors Chemistry; Metallurgy 42 Active
US7351834B1 ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Chemistry; Metallurgy 40 Expired
US6344476B1 Inhibition of p38 kinase activity by aryl ureas Emerging Cross-Sectional Technologies 35 Expired
US7625915B2 Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas Chemistry; Metallurgy 32 Active
US6911443B2 Imidazopyrimidine derivatives and triazolopyrimidine derivatives Human Necessities 28 Expired
US7897623B2 ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors Emerging Cross-Sectional Technologies 26 Active
US7528255B2 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors Chemistry; Metallurgy 25 Expired
US6849638B2 4-AMINO-5,6-SUBSTITUTED THIOPHENO [2,3-D] PYRIMIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND THEIR USE IN THE TREATMENT OR PREVENTION OF PDE7B-MEDIATED DISEASES AND CONDITIONS Chemistry; Metallurgy 21 Expired
US8124630B2 ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Chemistry; Metallurgy 19 Expired
US7517880B2 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas Emerging Cross-Sectional Technologies 18 Expired
US6784167B2 17-beta-hydroxysteroid dehydrogenase-II inhibitors Chemistry; Metallurgy 18 Expired
US8466283B2 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Chemistry; Metallurgy 16 Active
US8242147B2 Aryl ureas with angiogenisis inhibiting activity Emerging Cross-Sectional Technologies 16 Active
US8618141B2 Aryl ureas with angiogenesis inhibiting activity Emerging Cross-Sectional Technologies 15 Active
US7557129B2 Cyanopyridine derivatives useful in the treatment of cancer and other disorders Chemistry; Metallurgy 14 Expired
US7371763B2 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas Human Necessities 14 Expired
US7928239B2 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas Chemistry; Metallurgy 11 Expired
US6353006B1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents Chemistry; Metallurgy 11 Expired
US7928227B2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders Chemistry; Metallurgy 9 Expired
USRE46856E1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis General 9 Active
US8859572B2 Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis Human Necessities 9 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.